Padma Vibhusan Dr. Vikram Sarabhai(1919 – 1971)
Founder of various organizations like:
  • Indian Space Research Organization (ISRO)
  • Nehru Foundation for Development (NFD)
  • Indian Institutes of Management (IIMs)
  • Ahmedabad Textiles Industrial Research Association (ATIRA)
  • Operations Research Group (ORG)
  • Sarabhai chemicals

Sarabhai Chemicals is one of the first integrated pharmaceutical Giants in India. It ranked among the top 10 healthcare companies. Pharmacy business of ASE Ltd was diversified into Sarabhai Chemicals, S G Pharmaceuticals, Sarabhai M Chemicals, Standard Chemicals and Synbiotics. Production of the group accounted for about 8% of total production of drugs & Pharmaceutical in India.

The journey of Sarabhai Chemicals in Oncology started since 1970 promoting Oncology Products of Bristol Mayer Squibb first time in India like Hydrea (Hydroxyurea) useful in the treatment of CML.

In 1997, Sarabhai Chemicals tied up with Chiron Biopharma of USA for their two biotech research products namely Proleukin (IL2) for MRCC & Cardioxane (Dexrazoxane) for Chemotherapy induced Cardio toxicity. These niche molecules were again first time in India launched by Sarabhai. Moreover Paxtal our own brand of Paclitaxel was also among the 1st few brands in India.

In late 2005, a Separate Oncology Division was carved & created to cover entire India. The Oncology Division thus enters with more baskets of products in the segment of Hematology, Solid Tumor & supportive segments.

Sarabhai Oncology currently covers 300 Medical Oncologists, 100 Hematologists and 300 Radiation Oncologists. Our products are approved in all the leading major Institution like Tata Hospital, Defense, Railways, and CGHS etc.

In 2012, Sarabhai Chemicals spreads it’s wings to fly for new destinations in different specialties like Infertility, Critical care and Dermatology & Cosmetology.

Today Sarabhai Chemicals is operating across the country with a trained field force of 50 people and planning to expand up to 200 by the end of this year 2013.


  • SG Pharmaceuticals started in collaboration with J R Geigy of Switzerland.
  • Sarabhai M Chemicals was pioneer in the manufacture of Vitamin-C in collaboration with E Merck of West Germany.
  • Standard Pharmaceuticals was a leading manufacturer of penicillin.
  • Synbiotics is the largest antibiotic manufacturing complex in India in the Pvt. Sector in collaboration with E R Squibb of USA.
  • SARABHAI CHEMICALS was the biggest manufacturers of Amphotericin, Streptomycin Sulphate and Tetracycline HCL.
  • SARABHAI CHEMICALS introduced highly purified insulin injections manufactured under technical collaboration with Biobras of Brazil which received enthusiastic response from the medical profession.
  • The full range of highly purified procine insulin launched and manufacturing started for human insulin products.
  • An oral formulation `Contramal' manufactured in collaboration with Grunenthal of Germany was launched for first time in India.


  • ORG Informatics Limited.
  • Joint venture with Global Asia Partners (GAP)
  • Leading system integrator with strong presence in IT solutions and Telecom sector with clients like ONGC, ITC, Infosys, LIC, MTNL, Hutch, Siemens etc.
  • Sarabhai Zydus Animal Health Ltd.
  • 50-50 joint venture with Zydus Cadila group, formed in 2001.
  • Veterinary care – one of the top 3 players in India
  • Vovantis Pvt Ltd – Effervescent Tablet Manufacturing Facility.
  • Novartis India Ltd – Marketing rights for Cardioxane.
  • Bristol Meyer Squibb ( BMS ) – Manufacturing rights for HYDREA.

Sarabhai Chemicals is operating its business network in across the country with 50 executives head quartered in various places from Srinagar to Trivandrum and Ahmedabad to Kolkata.

Today our network spreads across the country with 108 stockiest &distributors covering almost every corner of the country. Our other groups of business like Generic version products are spreads to micro places like villages.

Globally we are representing through Asence Pharma private Limited is a subsidiary company of Asence INC. USA - a New York based pharmaceutical company. Asence has several product lines that are sold worldwide.

Tablets | Effervescent Tablets | Powders | Injections | Lyophilized injections | Ointments | Creams | Gels


Mr. Kartikeya V Sarabhai – Chairman

Mr. Sarabhai has done his postgraduate studies at MIT –USA. He has a long association with the Sarabhai Business and Pharmaceutical sector. He has been a member of the board and appointed as a chairman in ASE. He is also involved in a number of policies initiated by the Government of India particularly in the environmental and educational fields. He is a Director in CEE (Centre for Environmental Education).

Mr. Mohal K. Sarabhai - Director

Mr. Sarabhai is a Mechanical Engineer from the University of WISCONSIN -Madison who started his career as an Engineer in the field of biomechanics residing in USA . He has been actively associated with the pharmaceutical industry since the last 15 years, having worked in India and in International markets. He has been associated with ASENCE Inc, USA since its inception in 2003 and currently is the President, CEO and Director of ASENCE, USA and ASENCE Pharma Pvt. Ltd, India. He is also managing director of Synbiotics Limited.

Mr. Harshkant Udani

Mr. Harshkant is the Director of Senaru Formulations Private Limited. He holds a Bachelors degree in Commerce as well as a Bachelors degree in Law (LLB). He joined Karamchand Premchand Private Limited in 1966 and since then has been associated with the Sarabhai Group.



Latest News

  • Launched successfully!!!

Our Group Companies